DRUG SAFETY & MEDICAL INFORMATION

Patient safety is of paramount importance to Jazz Pharmaceuticals. It is our ethical and regulatory responsibility to monitor the safety of the medicines we develop from their preclinical stage, throughout clinical testing and for as long as they are prescribed to patients. Timely reporting to Medical Safety is critical to enable compliance with regulatory requirements. Please note that if you are a patient reporting occurrence of adverse events or if you have questions about your condition, please contact your health care practitioner. Medical Safety and Medical Information personnel do not provide answers or advice about individual medical questions.

MEDICAL INFORMATION REQUESTS IN THE US

To report an adverse event or a product complaint, or to request information about our products, please call one of the product-specific telephone numbers listed below.

Erwinaze® (asparaginase Erwinia chrysanthemi) 1-800-520-5568
FazaClo® (clozapine) LD and HD orally disintegrating clozapine tablets 1-800-520-5568
Luvox CR® (fluvoxamine maleate) 1-800-520-5568
Prialt® (ziconotide) solution, intrathecal infusion 1-800-890-3098
Versacloz (clozapine, USP) oral suspension 1-800-520-5568
Xyrem® (sodium oxybate) 1-800-520-5568


Caphosol® (supersaturated Calcium Phosphate) is no longer being commercialized by Jazz Pharmaceuticals. For medical information or to report an adverse event or a product complaint, please call 1-302-319-3873 or email your request to medicalinformation-US@eusapharma.com.

MEDICAL INFORMATION REQUESTS IN THE EU AND REST OF THE WORLD

For medical information inquiries or to report an adverse event or a product complaint for Kidrolase®, Erwinase®, Defitelio®, Leukotac®, please call or send an email using the following contact details.

Belgium
For inquiries in:
• French +33 176728925 medinfo-fr@jazzpharma.com
• Dutch +31 207176898 medinfo-nl@jazzpharma.com
• German +49 3056796128 medinfo-de@jazzpharma.com
Canada: +1 800 520 5568 jazzcamc@dlss.com
France: 01 76 72 89 25
or for inquiries in French
+33 176728925
medinfo-fr@jazzpharma.com
Germany: 03 05 67 96 12 8
or for inquiries in German
+49 3056796128
medinfo-de@jazzpharma.com
Luxembourg:
For inquiries in:
• French +33 176728925 medinfo-fr@jazzpharma.com
• German +49 3056796128 medinfo-de@jazzpharma.com
Italy: 06 87 50 08 50
or for inquiries in Italian
+39 0687500850
medinfo-it@jazzpharma.com
Netherlands: 02 07 17 68 98
or for inquiries in Dutch
+31 207176898
medinfo-nl@jazzpharma.com
Portugal: 30 88 05 626
or for inquiries in Portuguese
+351 308805626
medinfo-pt@jazzpharma.com
Poland: 2 21 25 3377
or for inquiries in Polish
+48 221253377
medinfo-pl@jazzpharma.com
Spain: 91 41 42 493
or for inquiries in Spanish
+34 914142493
medinfo-es@jazzpharma.com
Switzerland:
For inquiries in:
• French +33 176728925 medinfo-fr@jazzpharma.com
• German +49 3056796128 medinfo-de@jazzpharma.com
• Italian +39 0687500850 medinfo-it@jazzpharma.com

UK

08 45 03 05 089
or for inquiries in English
+44 8450305089
medinfo-uk@jazzpharma.com
EU / RoW:   medinfo-int@jazzpharma.com



Caphosol®, Collatamp®, Custodiol®, Xenazine®, Fomepizole® or Nominative ATU products (France) are no longer being commercialized by Jazz Pharmaceuticals. For medical information inquiries or to report an adverse event or a product complaint for these products, please consult the EUSA Pharma website at www.eusapharma.com.